Two of the exceptions had abnormal Aß42, consistent with stage 2 preclinical AD [4]; these participants were 80 and 77 years of age, had higher-level educations (college degrees), and had Apoε 3/4 genotype. The gene discussed is APOE; the disease is Alzheimer disease.